Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
Jump to:
Id | http://purl.obolibrary.org/obo/dinto_DB00169
http://purl.obolibrary.org/obo/dinto_DB00169
|
---|---|
Preferred Name | cholecalciferol |
Synonyms |
C27H44O
(1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol
|
Type | http://www.w3.org/2002/07/owl#Class |
All Properties
label |
cholecalciferol
|
---|---|
prefLabel |
cholecalciferol
|
is metabolised by | |
Definition |
Derivative of 7-dehydroxycholesterol formed by ultraviolet rays breaking of the C9-C10 bond. It differs from ergocalciferol in having a single bond between C22 and C23 and lacking a methyl group at C24. [PubChem]
|
DBBrand |
provitina
delsterol
deparal
oleovitamin d3
vigorsan
provitamine
delta-d
vigantol
micro-dee
ricketon
ebivit
trivitan
provitamin d3
See more
See less
|
ATCCode |
A11CC05
|
modulates | |
SMILES |
CC(C)CCC[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
|
InChI |
InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1
|
CASRN |
67-97-0
|
prefixIRI |
obo2:dinto_DB00169
|
Synonym |
C27H44O
(1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol
|
binds |
See more
See less
|
InChIKey |
InChIKey=QYSXJUFSXHHAJI-YRZJJWOYSA-N
|
subClassOf | |
may interact with |
See more
See less
|
inhibits | |
related with | |
is substrate of | |
type | |
xref |
Wikipedia:http://en.wikipedia.org/wiki/Cholecalciferol
PharmGKB:PA164748138
Drugs Product Database (DPD):2242651
ChEBI:28940
PDRhealth:http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/vit_0265.shtml
Drugs.com:http://www.drugs.com/mtm/cholecalciferol.html
See more
See less
|
DBSynonym |
colecalciferol
vitamin d3
cc
calciol
(+)-vitamin d3
|
activates | |
AHFScode |
88:16.00
|
has pharmacological target |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |